HOPE MORGAN: Open Payments
NPI 1386289411 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 65 payments from 16 companies in 2025. Trend: 2023 $1,437 · 2024 $1,411 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $277 |
| Lundbeck LLC | 11 | $146 |
| Janssen Pharmaceuticals, Inc | 6 | $130 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| Teva Pharmaceuticals USA, Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Tris Pharma Inc | 3 | $59 |
Products named: VRAYLAR, REXULTI, Auvelity, AUSTEDO XR, SPRAVATO, INGREZZA, INVEGA SUSTENNA, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
